Erratum: Glycine receptor antibodies in PERM and related syndromes: Characteristics, clinical features and outcomes (Brain (2014) 137 (2178-2192) DOI:10.1093/brain/awu142);Glycine receptor antibodies in PERM and related syndromes: Characteristics, clinical features and outcomes

Brain

Volumn 137, Issue 8, 2014, Pages 2178-2192

  Carvajal González, Alexander ^a   Leite, M Isabel ^a   Waters, Patrick ^a   Woodhall, Mark ^a   Coutinho, Ester ^a   Balint, Bettina ^b   Lang, Bethan ^a   Pettingill, Philippa ^a   Carr, Aisling ^c   Sheerin, Una Marie ^d   Press, Raomand ^e   Lunn, Michael P ^f   Lim, Ming ^a   Maddison, Paul ^g   Meinck, H M ^b   Vandenberghe, Wim ^h   Vincent, Angela ^a  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^b INF 400 ^*  (Germany)

^c ROYAL VICTORIA HOSPITAL   (United Kingdom)

^d CHARING CROSS HOSPITAL   (United Kingdom)

^e KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^f NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^g QUEEN S MEDICAL CENTRE   (United Kingdom)

^h UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

autoantibody; autoimmune encephalitis; glycine receptor; progressive encephalomyelitis with rigidity and myoclonus; stiff person syndrome

Indexed keywords

AZATHIOPRINE; BACLOFEN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; GLUTAMATE DECARBOXYLASE ANTIBODY; GLYCINE RECEPTOR; GLYCINE RECEPTOR ALPHA SUBUNIT; GLYCINE RECEPTOR ANTIBODY; IMMUNOGLOBULIN; IMMUNOGLOBULIN G ANTIBODY; METHYLPREDNISOLONE; MONOCLONAL ANTIBODY; MYCOPHENOLIC ACID; PREDNISOLONE; RECEPTOR ANTIBODY; RITUXIMAB; STEROID; UNCLASSIFIED DRUG;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; ANIMAL TISSUE; ANTIBODY DETECTION; ANTIBODY PRODUCTION; ARTICLE; BRAIN STEM; CEREBROSPINAL FLUID LEVEL; CHILD; CLINICAL FEATURE; COHORT ANALYSIS; CONTROLLED STUDY; DEGRADATION; DEMYELINATING DISEASE; DISEASE CLASSIFICATION; DISEASE SEVERITY; DRUG MEGADOSE; EMBRYO; ENCEPHALOMYELITIS; EPILEPSY; FEMALE; FOLLOW UP; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOTHERAPY; IN VITRO STUDY; INTERNALIZATION; KIDNEY CELL; LYMPHOMA; LYSOSOME; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MYOCLONUS; NONHUMAN; ONSET AGE; OPTIC NERVE DISEASE; PARANEOPLASTIC NEUROPATHY; PATHOGENICITY; PLASMAPHERESIS; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGRESSIVE ENCEPHALOMYELITIS WITH RIGIDITY AND MYOCLONUS; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RANKIN SCALE; RELAPSE; RETROSPECTIVE STUDY; ROOM TEMPERATURE; SCHOOL CHILD; SPINAL CORD; SPINAL CORD TRANSSECTION; STEROID THERAPY; STIFF MAN SYNDROME; THYMOMA; TREATMENT OUTCOME; TREATMENT RESPONSE;

AUTOANTIBODY; AUTOIMMUNE ENCEPHALITIS; GLYCINE RECEPTOR; PROGRESSIVE ENCEPHALOMYELITIS WITH RIGIDITY AND MYOCLONUS; STIFF PERSON SYNDROME;

ADOLESCENT; ADULT; AGED; ANIMALS; ANTIBODIES; CHILD; CHILD, PRESCHOOL; COMORBIDITY; ENCEPHALOMYELITIS; EPILEPSIES, MYOCLONIC; FEMALE; GLUTAMATE DECARBOXYLASE; HEK293 CELLS; HUMANS; INFANT; MALE; MIDDLE AGED; MUSCLE RIGIDITY; MYOCLONUS; NEOPLASMS; OUTCOME ASSESSMENT (HEALTH CARE); POTASSIUM CHANNELS, VOLTAGE-GATED; PROSPECTIVE STUDIES; RATS; RECEPTORS, GLYCINE; STIFF-PERSON SYNDROME; SYNDROME; YOUNG ADULT;

EID: 84905018428     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/awu274     Document Type: Erratum

References (60)

1. Alexopoulos H, Dalakas MC. A critical update on the immunopathogenesis of Stiff Person Syndrome. Eur J Clin Invest 2010; 40: 1018-25.
2. Alexopoulos H, Akrivou S, Dalakas MC. Glycine receptor antibodies in stiff-person syndrome and other GAD-positive CNS disorders. Neurology 2013; 81: 1962-4.
3. Angus-Leppan H, Rudge P, Mead S, Collinge J, Vincent A. Autoantibodies in sporadic Creutzfeldt-Jakob disease. JAMA Neurol 2013; 70: 919-22.
4. Araki T, Yamano M, Murakami T, Wanaka A, Betz H, Tohyama M. Localization of glycine receptors in the rat central nervous system: An immunocytochemical analysis using monoclonal antibody. Neuroscience 1988; 25: 613-24.
5. Bourke D, Roxburgh R, Vincent A, Cleland J, Jeffery O, Dugan N, et al. Hypoventilation in glycine-receptor antibody related progressive encephalomyelitis, rigidity and myoclonus. J Clin Neurosci 2014; 21: 876-8.
6. Brown P, Marsden CD. The stiff man and stiff man plus syndromes. J Neurol 1999; 246: 648-52.
7. Cabot JB, Alessi V, Bushnell A. Glycine-like immunoreactive input to sympathetic preganglionic neurons. Brain Res 1992; 571: 1-18.
8. Chan DWS, Thomas T, Lim M, Ling S, Woodhall M, Vincent A. Focal status epilepticus and progressive dyskinesia: A novel phenotype for glycine receptor antibody-mediated neurological disease in children. Dev Med Child Neurol 2014, in press
9. Chang T, Alexopoulos H, McMenamin M, Carvajal-Gonzalez A, Alexander SK, Deacon R, et al. Neuronal surface and glutamic acid decarboxylase autoantibodies in nonparaneoplastic stiff person syndrome. JAMA Neurol 2013; 70: 1140-9.
10. Clardy SL, Lennon VA, Dalmau J, Pittock SJ, Jones HR Jr, Renaud DL, et al. Childhood onset of stiff-man syndrome. JAMA Neurol 2013; 70: 1531-6.
11. Clerinx K, Breban T, Schrooten M, Leite MI, Vincent A, Verschakelen J, et al. Progressive encephalomyelitis with rigidity and myoclonus: Resolution after thymectomy. Neurology 2011; 76: 303-4.
12. Costa M, Saiz A, Casamitjana R, Castaner MF, Sanmarti A, Graus F, et al. T-cell reactivity to glutamic acid decarboxylase in stiff-man syndrome and cerebellar ataxia associated with polyendocrine autoimmunity. Clin Exp Immunol 2002; 129: 471-8.
13. Dalakas MC, Fujii M, Li M, Lutfi B, Kyhos J, McElroy B. High-dose intravenous immune globulin for stiff-person syndrome. New Engl J Med 2001; 345: 1870-6.
14. Dale RC, Merheb V, Pillai S, Wang D, Cantrill L, Murphy TK, et al. Antibodies to surface dopamine-2 receptor in autoimmune movement and psychiatric disorders. Brain 2012; 135: 3453-3468.
15. Dalmau J, Gleichman AJ, Hughes EG, Rossi JE, Peng X, Lai M, et al. Anti- NMDA-receptor encephalitis: Case series and analysis of the effects of antibodies. Lancet Neurol 2008; 7: 1091-8.
16. Damasio J, Leite MI, Coutinho E, Waters P, Woodhall M, Santos MA, et al. Progressive encephalomyelitis with rigidity and myoclonus: The first pediatric case with glycine receptor antibodies. JAMA Neurol 2013; 70: 498-501.
17. Dieudonne S. Glycinergic synaptic currents in Golgi cells of the rat cerebellum. Proc Natl Acad Sci USA 1995; 92: 1441-5.
18. Drachman DB, Angus CW, Adams RN, Michelson JD, Hoffman GJ. Myasthenic antibodies cross-link acetylcholine receptors to accelerate degradation. N Engl J Med 1978; 298: 1116-22.
19. Dutertre S, Becker CM, Betz H. Inhibitory glycine receptors: An update. J Biol Chem 2012; 287: 40216-23.
20. Espay AJ, Chen R. Rigidity and spasms from autoimmune encephalomyelopathies: Stiff-person syndrome. Muscle Nerve 2006; 34: 677-90.
21. Geis C, Grunewald B, Weishaupt A, Wultsch T, Toyka KV, Reif A, et al. Human IgG directed against amphiphysin induces anxiety behavior in a rat model after intrathecal passive transfer. J Neural Transm 2012; 119: 981-5.
22. Geis C, Weishaupt A, Hallermann S, Grunewald B, Wessig C, Wultsch T, et al. Stiff person syndrome-Associated autoantibodies to amphiphysin mediate reduced GABAergic inhibition. Brain 2010; 133: 3166-80.
23. Hacohen Y, Wright S, Waters P, Agrawal S, Carr L, Cross H, et al. Paediatric autoimmune encephalopathies: Clinical features, laboratory investigations and outcomes in patients with or without antibodies to known central nervous system autoantigens. J Neurol Neurosurg Psychiatry 2013; 84: 748-55.
24. Hansen N, Grunewald B, Weishaupt A, Colaco MN, Toyka KV, Sommer C, et al. Human Stiff person syndrome IgG-containing hightiter anti-GAD65 autoantibodies induce motor dysfunction in rats. Exp Neurol 2013; 239: 202-9.
25. Harvey RJ, Depner UB, Wassle H, Ahmadi S, Heindl C, Reinold H, et al. GlyR alpha3: An essential target for spinal PGE2-mediated inflammatory pain sensitization. Science 2004; 304: 884-7.
26. Holmøy T, Skorstad G, Roste LS, Scheie D, Alvik K. Stiff person syndrome associated with lower motor neuron disease and infiltration of cytotoxic T cells in the spinal cord. Clin Neurol Neurosurg 2009; 111: 708-12.
27. Hughes EG, Peng X, Gleichman AJ, Lai M, Zhou L, Tsou R, et al. Cellular and synaptic mechanisms of anti-NMDA receptor encephalitis. J Neurosci 2010; 30: 5866-75.
28. Hutchinson M, Waters P, McHugh J, Gorman G, O'Riordan S, Connolly S, et al. Progressive encephalomyelitis, rigidity, and myoclonus: A novel glycine receptor antibody. Neurology 2008; 71: 1291-2.
29. Iizuka T, Leite MI, Lang B, Waters P, Urano Y, Miyakawa S, et al. Glycine receptor antibodies are detected in progressive encephalomyelitis with rigidity and myoclonus (PERM) but not in saccadic oscillations. J Neurol 2012; 259: 1566-73.
30. Irani SR, Bera K, Waters P, Zuliani L, Maxwell S, Zandi MS, et al. Nmethyl- D-Aspartate antibody encephalitis: Temporal progression of clinical and paraclinical observations in a predominantly non-Paraneoplastic disorder of both sexes. Brain 2010; 133: 1655-67.
31. Jarius S, Wildemann B. AQP4 antibodies in neuromyelitis optica: Diagnostic and pathogenetic relevance. Nat Rev Neurol 2010; 6: 383-92.
32. Koneczny I, Cossins J, Waters P, Beeson D, Vincent A. MuSK myasthenia gravis IgG4 disrupts the interaction of LRP4 with MuSK but both IgG4 and IgG1-3 can disperse preformed agrin-independent AChR clusters. PLoS One 2013; 8: E80695.
33. Lancaster E, Dalmau J. Neuronal autoantigens-Pathogenesis, associated disorders and antibody testing. Nat Rev Neurol 2012; 8: 380-90.
34. Legendre P. The glycinergic inhibitory synapse. Cell Mol Life Sci 2001; 58: 760-793.
35. Leite MI, Jacob S, Viegas S, Cossins J, Clover L, Morgan BP, et al. IgG1 antibodies to acetylcholine receptors in 'seronegative' myasthenia gravis. Brain 2008; 131: 1940-52.
36. Lynch JW. Molecular structure and function of the glycine receptor chloride channel. Physiol Rev 2004; 84: 1051-95.
37. Lynch JW. Native glycine receptor subtypes and their physiological roles. Neuropharmacology 2009; 56: 303-9.
38. Mas N, Saiz A, Leite MI, Waters P, Baron M, Castano D, et al. Antiglycine-receptor encephalomyelitis with rigidity. J Neurol Neurosurg Psychiatry 2011; 82: 1399-401.
39. Malter MP, Helmstaedter C, Urbach H, Vincent A, Bien CG. Antibodies to glutamic acid decarboxylase define a form of limbic encephalitis. Ann Neurol 2010; 67: 470-8.
40. McKeon A, Martinez-Hernandez E, Lancaster E, Matsumoto JY, Harvey RJ, McEvoy KM, et al. Glycine receptor autoimmune spectrum with stiff-man syndrome phenotype. JAMA Neurol 2013; 70: 44-50.
41. McKeon A, Robinson MT, McEvoy KM, Matsumoto JY, Lennon VA, Ahlskog JE, et al. Stiff-man syndrome and variants: Clinical course, treatments, and outcomes. Arch Neurol 2012; 69: 230-8.
42. Meinck HM. Startle and its disorders. Clin Neurophysiol 2006; 36: 357-64.
43. Meinck HM, Thompson PD. Stiff man syndrome and related conditions. Mov Disord 2002; 17: 853-66.
44. Paton JF, Richter DW. Role of fast inhibitory synaptic mechanisms in respiratory rhythm generation in the maturing mouse. J Physiol 1995; 484: 505-21.
45. Peeters E, Vanacker P, Woodhall M, Vincent A, Schrooten M, Vandenberghe W. Supranuclear gaze palsy in glycine receptor antibody- positive progressive encephalomyelitis with rigidity and myoclonus. Mov Disord 2013; 27: 1830-2.
46. Piotrowicz A, Thumen A, Leite MI, Vincent A, Moser A. A case of glycine- receptor antibody-Associated encephalomyelitis with rigidity and myoclonus (PERM): Clinical course, treatment and CSF findings. J Neurol 2011; 258: 2268-70.
47. Rampon C, Luppi PH, Fort P, Peyron C, Jouvet M. Distribution of glycine- immunoreactive cell bodies and fibers in the rat brain. Neuroscience 1996; 75: 737-55.
48. Saiz A, Blanco Y, Sabater L, Gonzales F, Bataller L, Casamijana R, et al. Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: Diagnostic clues for this association. Brain 2008; 131: 2553-63.
49. Song W, Chattipakorn SC, McMahon LL. Glycine-gated chloride channels depress synaptic transmission in rat hippocampus. J Neurophysiol 2006; 95: 2366-79.
50. Stern WM, Howard R, Chalmers RM, Woodhall MR, Waters P, Vincent A, et al. Glycine receptor antibody mediated Progressive Encephalomyelitis with Rigidity and Myoclonus (PERM): A rare but treatable neurological syndrome. Pract Neurol 2014; 14: 123-7.
51. Turner MR, Irani SR, Leite MI, Nithi K, Vincent A, Ansorge O. Progressive encephalomyelitis with rigidity and myoclonus: Glycine and NMDA receptor antibodies. Neurology 2011; 77: 439-43.
52. Tuzun E, Zhou L, Baehring JM, Bannykh S, Rosenfeld MR, Dalmau J. Evidence for antibody-mediated pathogenesis in anti-NMDAR encephalitis associated with ovarian teratoma. Acta Neuropathol 2009; 118: 737-43.
53. Vincent A, Bien CG, Irani SR, Waters P. Autoantibodies associated with diseases of the CNS: New developments and future challenges. Lancet Neurol 2011; 10: 759-72.
54. Waldvogel HJ, Baer K, Eady E, Allen KL, Gilbert RT, Mohler H, et al. Differential localization of gamma-Aminobutyric acid type A and glycine receptor subunits and gephyrin in the human pons, medulla oblongata and uppermost cervical segment of the spinal cord: An immunohistochemical study. J Comp Neurol 2010; 518: 305-28.
55. Warren JD, Scott G, Blumbergs PC, Thompson PD. Pathological evidence of encephalomyelitis in the stiff man syndrome with anti-GAD antibodies. J Clin Neurosci 2002; 9: 328-9.
56. Wässle H, Heinze L, Ivanova E, Majumdar S, Weiss J, Harvey RJ, et a.l. Glycinergic transmission in the Mammalian retina. Front Mol Neurosci 2009 2 6
57. Whiteley AM, Swash M, Urich H. Progressive encephalomyelitis with rigidity. Brain 1976; 99: 27-42.
58. Waters P, Jarius S, Littleton E, Leite MI, Jacob S, Gray B, et al. Aquaporin-4 antibodies in neuromyelitis optica and longitudinally extensive transverse myelitis. Arch Neurol 2008; 65: 913-9.
59. Xu TL, Gong N. Glycine and glycine receptor signaling in hippocampal neurons: Diversity, function and regulation. Prog Neurobiol 2010; 91: 349-61.
60. Zuliani L, Graus F, Giometto B, Bien C, Vincent A. Central nervous system neuronal surface antibody associated syndromes: Review and guidelines for recognition. J Neurol Neurosurg Psychiatry 2012; 83: 638-45.